Our products are for the unmet medical needs in its key therapeutic areas of cardiovascular, gastrointestinal, endocrinology and psychiatry (central nervous system).
Otsuka Pharma Scandinavia AB is working on three products for our territory in Nordic and Baltic States. Adacolumn® for Inflammatory bowel disease, Pletal®* for Intermittent claudication and Samsca®, the only registered vasopressin V2- receptor antagonist for the treatment of hyponatremia (low serum sodium concentration) associated with SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion) in adults.
For a more indepth look at the global products for Otsuka (including nutraceuticals) please click here.
* Pletal® is only for Swedish market.